Susquehanna International Group, LLP Cytosorbents Corp Call Options Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	BUY	$1.79 - $4.17 $27,029 - $62,967	15,100 New	15,100 $50,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $6,864 - $12,558	3,900 Added 17.65%	26,000 $57,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $24,192 - $35,532	-8,400 Reduced 27.54%	22,100 $70,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $36,400 - $50,492	5,200 Added 20.55%	30,500 $248,000
Q2 2021 Aug 11, 2021	SELL	$7.55 - $9.42 $201,585 - $251,514	-26,700 Reduced 51.35%	25,300 $191,000
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $153,901 - $214,676	18,700 Added 56.16%	52,000 $451,000
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $81,090 - $95,188	10,600 Added 46.7%	33,300 $265,000
Q3 2020 Nov 16, 2020	SELL	$7.37 - $11.54 $616,132 - $964,743	-83,600 Reduced 78.65%	22,700 $181,000
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $441,484 - $744,477	70,300 Added 195.28%	106,300 $1.05 Million
Q1 2020 May 15, 2020	BUY	$3.77 - $7.73 $135,720 - $278,280	36,000 New	36,000 $278,000
Q4 2018 Feb 14, 2019	SELL	$7.05 - $12.64 $192,465 - $345,072	-27,300 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $194,910 - $263,440	-17,800 Reduced 39.47%	27,300 $352,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $12.35 $244,950 - $438,425	-35,500 Reduced 44.04%	45,100 $514,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $232,525 - $291,100	35,500 Added 78.71%	80,600 $568,000
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $266,090 - $317,955	45,100	45,100 $293,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.